Küçükgüzel, Şükriye GünizSahin, Ahmet FatihKucukguzel, S. GunizAkdemir, AtillaEczacılık Meslek Bilimleri Bölümü2025-01-112025-01-11202112630-634410.29228/jrp.96https://doi.org/10.29228/jrp.96https://hdl.handle.net/20.500.14627/160Sahin, Ahmet Fatih/0000-0001-7802-8730In this study, molecular modelling study of previously synthesized compounds against SARS-CoV-2 target enzyme was performed. A subset of 156 compounds from an in-house database has been subjected to molecular modelling studies against the SARS-CoV-2 ADP-ribose phosphatase (ADRP, NSP3), Papain-like protease (PLpro), and uridine specific endoribonuclease (NSP15) enzymes. We have identified one compound that is expected to inhibit the SARS-CoV-2 ADRP enzyme and one compound that is expected to inhibit the NSP15 enzyme.eninfo:eu-repo/semantics/openAccessSars-Cov-2Covid-19AdrpPlproNsp15DockingMolecular DynamicsArticleQ425610101017WOS:000725063300028488949